Cambridge, United Kingdom

Basil Hartzoulakis

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 7.4

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • London, GB (2012)
  • Cambridge, GB (2011 - 2016)

Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Basil Hartzoulakis

Introduction

Basil Hartzoulakis is an accomplished inventor based in Cambridge, GB, with a remarkable portfolio of 11 patents. His work primarily focuses on compounds that serve as potassium channel inhibitors, showcasing his dedication to advancing medical science through innovative inventions.

Latest Patents

Among his latest patents is a groundbreaking invention related to potassium channel blockers. This invention encompasses a compound of formula (I) or its salts or pharmaceutically acceptable derivatives, designed to inhibit potassium ion channels. Another significant patent includes thieno-pyrimidines, which are identified as potassium channel inhibitors. The invention details pharmaceutical compositions using these compounds for therapeutic purposes, particularly targeting diseases related to K3.1 and K3.4 channels.

Career Highlights

Throughout his career, Basil has made significant contributions in his field. His role in renowned companies such as Xention Limited and UCL Business Plc has allowed him to refine his innovative capabilities and collaborate with other experts in pharmaceutical research and development.

Collaborations

Basil Hartzoulakis has worked alongside esteemed colleagues, including David John Madge and Derek Edward John. Their collective expertise has likely enhanced the research and development efforts surrounding his inventions, ultimately benefiting the medical community.

Conclusion

Basil Hartzoulakis stands out as a visionary inventor whose work in potassium channel inhibition signifies a vital contribution to therapeutic developments. His extensive patent portfolio reflects his commitment to innovation and his ability to collaborate effectively in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…